Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.

Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 ...

Eli Lilly and Co. is in negotiations with several states and plans to announce the locations of four new manufacturing plants ...

Eli Lilly and Co. Wednesday announced ... 13,000 manufacturing and construction jobs. Lilly will invest $27 billion in the four plants, the Indianapolis drugmaker announced at a press conference ...

The new manufacturing sites are expected to create create 3,000 pharmaceutical jobs and nearly 10,000 construction positions during the buildout.

Eli Lilly said Wednesday it will invest $27 billion ... the threat of drug import duties from the Trump administration. The Indianapolis-based company said three of the planned facilities will ...

Novo Nordisk said Wednesday it will sell Wegovy for $499 a month in cash to patients who can’t get the blockbuster weight-loss drug through insurance, a bid to reach consumers who can’t afford the $1, ...

Eli Lilly wants the most optimal locations to host its new manufacturing facilities in the U.S.—and it’s open to pitche | Eli ...

INDIANAPOLIS — Eli Lilly and Company is announcing a massive new set of investments in U.S. manufacturing. The company plans to more than double its investments since 2020, bringing the total to more ...

the Indianapolis-based drug giant said Wednesday. David Ricks, Eli Lilly’s chief executive officer, told CNN that the company – whose revenue grew 32% to $45 billion last year on the back of ...